$600M settlement between Alibaba and DOJ over illegal pharma sales slipping through their platforms.
No admission of guilt. No trial. Just write the check and move on.
Alibaba declined to comment, which is basically the playbook at this point.
For a company that scale, $600M is just the price of making noise go away. Not even a speed bump on the balance sheet.
Regulatory risk is real, but when you're big enough, it's just another line item.
No admission of guilt. No trial. Just write the check and move on.
Alibaba declined to comment, which is basically the playbook at this point.
For a company that scale, $600M is just the price of making noise go away. Not even a speed bump on the balance sheet.
Regulatory risk is real, but when you're big enough, it's just another line item.